|Videos|June 29, 2022

Future Perspectives in Renal Cell Carcinoma (RCC)

Author(s)Thomas Hutson, DO, PharmD

Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Molecular testing helps distinguish kidney cancer subtypes, ensuring patients get accurate diagnoses and treatment plans, avoiding unnecessary surgery.

Molecular Testing Improves Accuracy in Kidney Cancer Diagnosis

BySpencer Feldman

September 22nd 2025

Picture of Dr. Ravi Munver

Understanding Recent Treatment Advancements in Kidney Cancer Care

September 22nd 2025

Dr. Ravi Munver

Advances in Kidney Cancer Allow Less Invasive and More Personalized Care

ByDr. Ravi Munver

September 20th 2025

Obtaining an accurate diagnosis is a crucial first step in kidney cancer care, according to Dr. Shuanzeng “Sam” Wei of Fox Chase Cancer Center.

Accurate Kidney Cancer Diagnosis is Key to Effective Treatment

ByDr. Shuanzeng “Sam” Wei

September 19th 2025

Image of Linda.

The Defining Moments of Support After Hearing ‘You Have Cancer’

September 17th 2025

Trending on CURE

All FDA Oncology Approvals From September 2025

FDA Approves Zepzelca Plus Tecentriq for Extensive-Stage Small Cell Lung Cancer

Pelvic Physical Therapy After Cancer Restores Intimacy, Wellness

FDA Approves Enoby and Xtrenbo Biosimilars for Bone Health and Cancer Care

September Blood Cancer Updates: What Patients Should Know

© 2025 MJH Life Sciences^®

All rights reserved.